Latest news for Charlies Hldgs (OTC:CHUC) Stock

Charlies Holdings Inc is engaged in the formulation, marketing, and distribution of e-cigarette liquid which is used in both open and closed consumer e-cigarette and vaping systems. In addition, the firm engages in the production of premium vapor, tincture, and topical products containing hemp-derived cannabidiol. Geographically, it derives a majority of its revenue from the United States.

Cannabis

Earnings

News

Penny Stocks

Markets

CHUC

Charlie&#39;s Holdings, Inc. (OTCQB: CHUC) revenue for the year ended December 31, 2022, was $26.4 million, an increase of 23%, compared with $21.5 million for the year ended December 31, 2021.

Charlie&#39;s Holdings FY22 Revenue Grows 23% To $26.4M, Here Is What You Need To Know

Movers & Shakers

Intraday Update

Movers

Trading Ideas

General

AGHC

AGUNF

ALEAFIA HEALTH INC ORD by Aleafia Health Inc.

ALEAF

ANCN

AREVF

ARST

ATRX

AUSAF

AXMIF

BIOC

BLPH

BRTX

BRVVF

CANX

CBYDF

CCAN

CGIX

CHEK

CHOOF

CNAB

CRMZ

CRON

CTDT

CTRA

CVEO

DLPH

DSWL

EBIX

ECEZ

ECORF

EMERALD HEALTH THERAPUTCS by Emerald Health Therapeutics Inc.

EMHTF

ETEC

FFLWF

FLNT

FOSL

GILT

HCMC

HEXO

HRVOF

HSDT

LGORF

LIVX

LOVE

LTRPB

LUCRF

MENEF

MEPW

MGTI

MITK

MRKR

MRRMF

NAII

NEWM

NGBL

NMKEF

NMRD

NRGMF

NUGL

NVEE

NVTR

OBSV

OPGN

OPTT

PACXF

PFSCF

PNNT

PXPP

QUAD

QUIK

RAIL

RBBN

RDDTF

RMTD

ROYT

RSPI

RTLR

RIGHT ON BRANDS INC by Right On Brands, Inc.

RTON

RAVENQUEST BIOMED INC by Ravenquest Biomed Inc.

RVVQF

RWLK

SDRL

SGBX

SIPC

Stocks That Hit 52-Week Lows On Friday

ADGO

AFOM

AKER

ANDR

APAAF

ARXRF

ASDN

ASPCF

ASTC

BBGI

BERK

BIEI

BRGO

BTLLF

BWSOF

CAMZF

CASA

CBDS

CCTR

CIIX

CLABF

CLSN

CNBX

CNSNF

CPPMF

CPPXF

CRNT

CWEGF

DJIFF

DNJR

DPWW

DYNT

EIPC

ELBSF

FBCD

FBEC

FCOB

FELP

FERL

FFNTF

FRLF

GAXY

GGISF

GHIFF

GRST

HABC

HCAP

HEWA

HLIX

HPMM

HRTFF

HSSHF

HVBTF

INTERNATIONAL ENDEAVORS by International Endeavors Corp

IDVV

IFMK

IMAC

IPICQ

IRNC

ISAT

JCAP

JFIN

KHIRON LIFE SCIENCES CORP by Khiron Life Sciences Corp.

KHRNF

KWBT

LENSF

LLBO

LLLI

LTNC

LUVU

MGWFF

MGXMF

MLHC

MRSN

MYDP

MYHI

NOHO

NVSGF

ONCX

ORHOF

OTTV

OZSC

POTRF

PPSI

PTEEF

RASFQ

RDWD

RITE

RMSL

RMTI

ROKK

Stocks That Hit 52-Week Lows On Monday

CHARLIES HOLDINGS INC by Charlie's Holdings, Inc.

Charlies Holdings Inc

<p>Baker Hughes (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BKR#NASDAQ">BKR</a>) reported quarterly earnings of $0.70 per share which beat the analyst consensus estimate of $0.63 by 11.11 percent. This is a 37.25 percent increase over earnings of $0.51 per share from the same period last year.  The company reported quarterly sales of $7.36 billion which beat the analyst consensus estimate of $7.08 billion by 4.04 percent.  This is a 7.74 percent increase over sales of $6.83 billion the same period last year.</p>


Earnings Beats

Baker Hughes Q4 2024 Adj EPS $0.70 Beats $0.63 Estimate, Sales $7.36B Beat $7.08B Estimate

<p>Across the recent three months, 4 analysts have shared their insights on AGNC Investment (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGNC#NASDAQ">AGNC</a>), expressing a variety of opinions spanning from bullish to bearish.</p>
<p>The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $10.25, with a high estimate of $11.00 and a low estimate of $9.50. This current average represents a 2.38% decrease from the previous average price target of $10.50. </p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1738274475_0.png" alt="price target chart" /></p>
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
<p>An in-depth analysis of recent analyst actions unveils how financial experts perceive AGNC Investment. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Kenneth Lee</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$11.00</td>
<td>$11.00</td>
</tr>
<tr>
<td>Jason Weaver</td>
<td>Jones Trading</td>
<td>Maintains</td>
<td>Buy</td>
<td>$10.25</td>
<td>$10.25</td>
</tr>
<tr>
<td>Bose George</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$10.25</td>
<td>$10.75</td>
</tr>
<tr>
<td>Richard Shane</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$9.50</td>
<td>$10.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to AGNC Investment. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of AGNC Investment compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts explore the dynamics of price targets, providing estimates for the future value of AGNC Investment's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
<p>For valuable insights into AGNC Investment's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/AGNC/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on AGNC Investment analyst ratings.</strong></a></p>
<h2>Discovering AGNC Investment: A Closer Look</h2>
<p>AGNC Investment Corp is a real estate investment trust that invests in agency residential mortgage-backed securities. The firm's asset portfolio is comprised of residential mortgage pass-through securities and collateralized mortgage obligations for which the principal and interest payments are guaranteed by a U.S. Government-sponsored enterprise, such as the Federal National Mortgage Association and the Federal Home Loan Mortgage Corporation, or by a U.S. Government agency, such as the Government National Mortgage Association. It also invests in other types of mortgage and mortgage-related residential and commercial mortgage-backed securities or other investments in or related to, the housing, mortgage or real estate markets.</p>
<h3>AGNC Investment: Delving into Financials</h3>
<p><strong>Market Capitalization Highlights:</strong> Above the industry average, the company's market capitalization signifies a significant scale, indicating strong confidence and market prominence.</p>
<p><strong>Revenue Challenges:</strong> AGNC Investment's revenue growth over 3 months faced difficulties. As of 31 December, 2024, the company experienced a decline of approximately <strong>-59.04%</strong>. This indicates a decrease in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Financials sector.</p>
<p><strong>Net Margin:</strong> The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of <strong>55.84%,</strong> the company showcases strong profitability and effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> AGNC Investment's ROE stands out, surpassing industry averages. With an impressive ROE of <strong>1.06%</strong>, the company demonstrates effective use of equity capital and strong financial performance.</p>
<p><strong>Return on Assets (ROA):</strong> The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of <strong>0.1%,</strong> the company may need to address challenges in generating satisfactory returns from its assets.</p>
<p><strong>Debt Management:</strong> The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at <strong>0.01</strong>.</p>
<h2>Analyst Ratings: Simplified</h2>
<p>Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.</p>
<p>In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.</p>
<p><strong>Breaking: Wall Street's Next Big Mover</strong></p>
<p>Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights"><strong>Click here for urgent details</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Analyst Ratings

Assessing AGNC Investment: Insights From 4 Financial Analysts

Comments

Charlies Hldgs

News

Latest news for Charlies Hldgs (OTC:CHUC) Stock

Tuesday, April 18, 2023

Friday, November 15, 2019

Monday, November 04, 2019

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga